PBE

Fund Description
The Invesco Dynamic Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Fund Profile
Fund Name Invesco Dynamic Biotechnology & Genome ETF
Fund Exchange Ticker PBE
Fund Sponsor Invesco
Fund ISIN US46137V7872
Net Expense Ratio 0.57 %
Fund Inception Date 23 June 2005
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Dynamic Biotechnology & Genome Intellidex Index
Index Provider NYSE
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 14 January 2021
Asset Under Management 286.26 Million (USD)
1 Month Total Return 10.00 %
Year To Date Return 8.70 %
1 Year Total Return 33.82 %
3 Year Annualized Total Return 15.06 %
NAV 76.337
Share Outstanding 3,750,000
Top 10 Holdings (14 January 2021)
Constituent Name Constituent Ticker Constituent Type Weighting
INTELLIA THERAPEUTICS INC NTLA EQUI 0.0528913645
ALEXION PHARMACEUTICALS INC ALXN EQUI 0.0515612044
CATALENT INC CTLT EQUI 0.0493312015
REPLIGEN CORP RGEN EQUI 0.0480078692
BIOGEN INC BIIB EQUI 0.0468336028
QIAGEN N.V. QGEN EQUI 0.0462914277
BIO-TECHNE CORP TECH EQUI 0.0451219400
SEAGEN INC SGEN EQUI 0.0432855753
VERTEX PHARMACEUTICALS INC VRTX EQUI 0.0423221026
FULGENT GENETICS INC FLGT EQUI 0.0413271179